VREX · Varex Imaging Corp
$10.94
+0.22 (+2.05%)
At close · Jul 24
Market Cap
$459.73M
Shares
42.10M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$844.6M
+4.1%
FY2025
Net Income
-$70.3M
-47.4%
FY2025
Gross Margin
34.39%
+2.7pp
FY2025
Operating Margin
-3.29%
-7.2pp
FY2025
Diluted EPS
-$1.70
-45.3%
FY2025
Operating Cash Flow
$41.7M
-11.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $860M – $880M | $857.5M | $844.6M | $811M | $893.4M | $859.4M | $818.1M | $738.3M | $780.6M | $773.4M | $698.1M | |
| — | $569.8M | $554.1M | $554.1M | $603.1M | $575.9M | $546.6M | $548.1M | $523.9M | $519.5M | $444.6M | |
| — | $287.7M | $290.5M | $256.9M | $290.3M | $283.5M | $271.5M | $190.2M | $256.7M | $253.9M | $253.5M | |
| — | — | 34.39% | 31.68% | 32.49% | 32.99% | 33.19% | 25.76% | 32.88% | 32.83% | 36.31% | |
| — | $89.5M | $91.1M | $87M | $84.8M | $77M | $71.9M | $78.9M | $78.1M | $83M | $67.3M | |
| — | $135.6M | $133.3M | $137.8M | $128.4M | $118.3M | $125.5M | $142.2M | $128.1M | $126.4M | $102.5M | |
| — | $4.3M | $4M | $9.9M | $13.7M | $14.6M | $16.8M | $17.2M | $15.7M | $16.2M | $10.5M | |
| — | $319M | $318.3M | $224.8M | $213.2M | $195.3M | $197.4M | $223.9M | $211M | $209.4M | $169.8M | |
| — | -$31.3M | -$27.8M | $32.1M | $77.1M | $88.2M | $74.1M | -$33.7M | $45.7M | $44.5M | $83.7M | |
| — | — | -3.29% | 3.96% | 8.63% | 10.26% | 9.06% | -4.56% | 5.85% | 5.75% | 11.99% | |
| — | $42.4M | $35.5M | $30.2M | $29.3M | $39.8M | $42.1M | $31.4M | $21.1M | $21.7M | $12.3M | |
| — | $4.5M | $8.5M | $7.3M | $3.7M | $400K | $100K | $100K | $100K | $200K | $200K | |
| — | -$43.8M | -$31.4M | -$27.1M | -$45.8M | -$43.7M | -$45.5M | -$38.9M | -$24.2M | -$18.8M | -$8.9M | |
| — | — | -$2.3M | -$1M | -$1.4M | -$3M | -$3.4M | -$2.1M | -$2.3M | $3.9M | $1.3M | |
| — | -$75.1M | -$59.2M | $5M | $31.3M | $44.5M | $28.6M | -$72.6M | $21.5M | $25.7M | $74.8M | |
| — | $7.4M | $10.7M | $52.2M | -$17.4M | $13.7M | $10.7M | -$15.2M | $5.7M | -$2.6M | $22.8M | |
| — | -$82.7M | -$70.3M | -$47.7M | $48.2M | $30.3M | $17.4M | -$57.9M | $15.5M | $27.5M | $51.6M | |
| — | — | -8.32% | -5.88% | 5.4% | 3.53% | 2.13% | -7.84% | 1.99% | 3.56% | 7.39% | |
| — | $200K | $400K | $500K | $500K | $500K | $500K | $500K | $300K | $800K | $400K | |
| — | — | — | — | — | $30.3M | — | — | — | — | — | |
| — | -$85.9M | -$72.6M | -$49.4M | $46.9M | $30.4M | $16.6M | -$55.4M | $8M | $32.5M | $52.4M | |
| USD/shares | — | — | -$1.70 | -$1.17 | $1.20 | $0.76 | $0.44 | -$1.49 | $0.41 | $0.73 | $1.37 |
| USD/shares | $0.80 – $1.00* | — | -$1.70 | -$1.17 | $1.08 | $0.73 | $0.43 | -$1.49 | $0.40 | $0.72 | $1.36 |
| shares | — | — | 41.4M | 40.8M | 40.3M | 39.8M | 39.3M | 38.8M | 38.2M | 37.9M | 37.6M |
| shares | — | — | 41.4M | 40.8M | 50.3M | 41.6M | 40.3M | 38.8M | 38.6M | 38.4M | 38M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.84×
Medical Devices median 2.14×
EV/EBIT
—
Medical Devices median 21.03×
P/E (TTM)
—
Medical Devices median 27.62×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Medical Segment | $592,600,000 | $581,700,000 | $673,300,000 | — | — | — | — | — |
| Industrial Segment | $252,000,000 | $229,300,000 | $220,100,000 | — | — | — | — | — |
| Industrial | — | — | — | — | — | $153,800,000 | $183,800,000 | $171,400,000 |
| Industrial Segment | — | — | — | $184,700,000 | $174,300,000 | — | — | — |
| Medical | — | — | — | — | — | $584,500,000 | $596,800,000 | $602,000,000 |
| Medical Segment | — | — | — | $674,700,000 | $643,800,000 | — | — | — |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Other Countries | $317,900,000 | $317,200,000 | $314,900,000 | — | — | — | — | — |
| United States | $254,900,000 | $257,700,000 | $275,100,000 | $263,700,000 | $262,300,000 | $249,800,000 | $275,300,000 | $268,800,000 |
| Japan | $143,500,000 | $118,100,000 | $156,600,000 | — | — | — | — | — |
| China | $128,300,000 | $118,000,000 | $146,800,000 | — | — | — | — | — |
| Americas | — | — | — | $273,300,000 | $268,500,000 | $255,000,000 | $282,600,000 | — |
| Asia Pacific | — | — | — | $305,300,000 | $273,300,000 | $251,800,000 | $229,000,000 | $243,100,000 |
| Latin America | — | — | — | — | — | $5,200,000 | $7,300,000 | $7,000,000 |
| EMEA | — | — | — | $280,800,000 | $276,300,000 | $231,500,000 | $269,000,000 | $254,500,000 |